English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [5494]
News [13155]
Articles [201]
Editorials [5]
Conferences [263]
elearning [17]
Immunotherapy plus chemotherapy before surgery shows promise for pancreatic cancer
Immunotherapy plus chemotherapy before surgery shows promise for pancreatic cancer
Enhanced pulmonary nodule detection and classification using artificial intelligence on LIDC-IDRI data
Enhanced pulmonary nodule detection and classification using artificial intelligence on LIDC-IDRI data
Maps can encourage home radon testing in the right settings
Maps can encourage home radon testing in the right settings
Telehealth improves access to genetic services for adult survivors of childhood cancers
Telehealth improves access to genetic services for adult survivors of childhood cancers
Radiotherapy is more effective when administered at the right time of day
Radiotherapy is more effective when administered at the right time of day
Unraveling the mystery of why some cancer treatments stop working
Unraveling the mystery of why some cancer treatments stop working
Overall survival benefit with elenagen plus gemcitabine in platinum-resistant ovarian cancer
Overall survival benefit with elenagen plus gemcitabine in platinum-resistant ovarian cancer
HPV cancer vaccine slows tumour growth, extends survival in preclinical model
HPV cancer vaccine slows tumour growth, extends survival in preclinical model
Antibody-drug conjugate achieves high response rates as frontline treatment in aggressive, rare blood cancer
Antibody-drug conjugate achieves high response rates as frontline treatment in aggressive, rare blood cancer
FDA approves pembrolizumab with paclitaxel for platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal carcinoma
FDA approves pembrolizumab with paclitaxel for platinum-resistant epithelial ovarian, fallopian tube, or primary...
<1…56789…1316>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2026 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top